Rhythm Biosciences Ltd has released a press release.
Rhythm Closes Final Clinical Trial Site
Filed with ASX ·
6ix hasn’t read this filing yet.
Rhythm Biosciences Limited on 6ix
Story so far
Earlier from Rhythm Biosciences
- Appendix 4C - quarterly
- Rhythm Biosciences: RHY Presentation at PAC Partners Healthcare Conference
- Rhythm Biosciences - Investor Presentation
- Study 7 Confirms ColoSTAT Meets Primary Endpoint
- S&P DJI Announces March 2022 Quarterly Rebalance
Later from Rhythm Biosciences
- Completion of Final TGA Submission Step to Approve ColoSTAT
- Application for quotation of securities - RHY
- RHY Advances Platform Expansion with Other Cancers
- Director Share Sale To Institutional Funds Manager
- Rhythm Receives $2.7m R&D Tax Incentive
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences